LMTK3 and breast cancer: miR-34a is known to have a tumour suppressor role; however, this study further demonstrated that the oncogenic miRNA, miR-182, also has a tumour suppressor role in breast cancer cells overexpressing LMTK3, highlighting the complex signalling network surrounding LMTK3 regulation.